Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 5 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Fulcrum Therapeutics Inc have a median target of 4.00, with a high estimate of 14.00 and a low estimate of 2.00. The median estimate represents a 19.05% increase from the last price of 3.36.
High | 316.7% | 14.00 |
Med | 19.0% | 4.00 |
Low | -40.5% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | -4.23% |
Average growth rate | +27.97% |
More ▼
Revenue history & estimates in USD
Average growth rate | -33.00% |
Average growth rate | -1.83% |
More ▼